Cargando…
Development of Folate Receptor−Targeted PET Radiopharmaceuticals for Tumor Imaging—A Bench-to-Bedside Journey
The folate receptor-α (FR-α) is overexpressed in many epithelial cancers, including ovary, uterus, kidneys, breast, lung, colon and prostate carcinomas, but shows limited expression in normal tissues such as kidneys, salivary glands, choroid plexus and placenta. FR-α has therefore emerged as a promi...
Autores principales: | Boss, Silvan D., Ametamey, Simon Mensah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352234/ https://www.ncbi.nlm.nih.gov/pubmed/32527010 http://dx.doi.org/10.3390/cancers12061508 |
Ejemplares similares
-
SPECT and PET radiopharmaceuticals for molecular imaging of apoptosis: from bench to clinic
por: Wang, Xiaobo, et al.
Publicado: (2017) -
PAI-1 and Diabetes: A Journey From the Bench to the Bedside
por: Schneider, David J., et al.
Publicado: (2012) -
Editorial: Combination Therapy for Hypothyroidism: The Journey From Bench to Bedside
por: Jonklaas, Jacqueline, et al.
Publicado: (2020) -
RISUG(®) as a male contraceptive: journey from bench to bedside
por: Khilwani, Barkha, et al.
Publicado: (2020) -
Cannabis, the Endocannabinoid System and Immunity—the Journey from the Bedside to the Bench and Back
por: Almogi-Hazan, Osnat, et al.
Publicado: (2020)